Weili Si
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Weili Si has a total of 88 co-authors. Here are the top co-authors by number of shared publications:
- Xiaochen Dong
Jiangsu Normal University
26 shared publications Wenjun Wang
School of Physical Science and Information Technology, Liaocheng University, Liaocheng, China
13 shared publicationsWei Huang
Shaanxi Institute of Flexible Electronics (SIFE) Northwestern Polytechnical University (NPU) 127 West Youyi Road Xi'an 710072 China
8 shared publicationsRui Gu
Key Laboratory of Flexible Electronics (KLOFE) & Institute of Advanced Materials (IAM), Nanjing Tech University (NanjingTech), Nanjing, China
6 shared publicationsXiaoyu Huang
Key Laboratory of Flexible Electronics (KLOFE) & Institute of Advanced Materials (IAM)
6 shared publicationsJianhua Zou
Key Laboratory of Flexible Electronics (KLOFE) & Institute of Advanced Materials (IAM), Nanjing Tech University (NanjingTech), Nanjing, China
5 shared publications
Latest Publications
- Open Access
- 9 November 2023
- Published by Wiley in Advanced Functional Materials
- Vol. 33 (46)
“Wax‐Sealed” Theranostic Nanoplatform for Enhanced Afterglow Imaging–Guided Photothermally Triggered Photodynamic Therapy
- 9 November 2023
- Published by Wiley in Advanced Functional Materials
- Vol. 33 (46)
Open Access“Wax‐Sealed” Theranostic Nanoplatform for Enhanced Afterglow Imaging–Guided Photothermally Triggered Photodynamic Therapy
- 21 January 2023
- Published by Tsinghua University Press in Nano Research
- Vol. 16 (5) , 7373-7382
Biomineralized CO gas-releasing nanoprodrug for endoplasmic reticulum stress mediated cancer therapy
The anti-tumor effect of therapeutic carbon monoxide (CO) has been considered concerning the electron transport chain on the inner mitochondrial membrane. Herein, a tumor microenvironment and photo-responsive CO nanoplatform Ca-Flav nanoparticles (NPs) were constructed through biomineralizing acryloyl-modified flavonol, which could release CO both in normoxia and hypoxia conditions upon irradiation at tumor lesion. The in vitro experiments demonstrated that the endoplasmic reticulum stress-related signal pathways could be activated through oxidative stress caused by CO mediated mitochondrial biogenesis and calcium ion turbulence induced by Ca3(PO4)2 acidolysis, resulting in mitochondrial dysfunction and cell apoptosis. In addition, the Ca-Flav NPs exhibited excellent biocompatibility and tumor inhibition effect in vivo. This work provides new insight into the potential characteristics of CO, paving a new way to engineer more efficient treatment based on CO.
- 21 January 2023
- Published by Tsinghua University Press in Nano Research
- Vol. 16 (5) , 7373-7382
Biomineralized CO gas-releasing nanoprodrug for endoplasmic reticulum stress mediated cancer therapy
The anti-tumor effect of therapeutic carbon monoxide (CO) has been considered concerning the electron transport chain on the inner mitochondrial membrane. Herein, a tumor microenvironment and photo-responsive CO nanoplatform Ca-Flav nanoparticles (NPs) were constructed through biomineralizing acryloyl-modified flavonol, which could release CO both in normoxia and hypoxia conditions upon irradiation at tumor lesion. The in vitro experiments demonstrated that the endoplasmic reticulum stress-related signal pathways could be activated through oxidative stress caused by CO mediated mitochondrial biogenesis and calcium ion turbulence induced by Ca3(PO4)2 acidolysis, resulting in mitochondrial dysfunction and cell apoptosis. In addition, the Ca-Flav NPs exhibited excellent biocompatibility and tumor inhibition effect in vivo. This work provides new insight into the potential characteristics of CO, paving a new way to engineer more efficient treatment based on CO.
- 19 August 2022
- Published by Royal Society of Chemistry (RSC) in Green Chemistry
- Vol. 24 (18) , 6830-6835
Photoinduced allylic defluorinative alkylation of trifluoromethyl alkenes with Katritzky salts under catalyst- and metal-free conditions
A photoinduced method for the synthesis of gem-difluoroalkenes using trifluoromethyl alkenes and Katritzky salts under catalyst- and metal-free conditions is described.
- 19 August 2022
- Published by Royal Society of Chemistry (RSC) in Green Chemistry
- Vol. 24 (18) , 6830-6835
Photoinduced allylic defluorinative alkylation of trifluoromethyl alkenes with Katritzky salts under catalyst- and metal-free conditions
A photoinduced method for the synthesis of gem-difluoroalkenes using trifluoromethyl alkenes and Katritzky salts under catalyst- and metal-free conditions is described.
- Open Access
- 20 July 2022
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 13 (32) , 9401-9409
Crystal engineering of ferrocene-based charge-transfer complexes for NIR-II photothermal therapy and ferroptosis
Organic charge-transfer complexes (CTCs) can function as versatile second near-infrared (NIR-II) theranostic platforms to tackle complicated solid tumors, while the structure–property relationship is still an unanswered problem. To uncover the effect of molecular stacking modes on photophysical and biochemical properties, herein, five ferrocene derivatives were synthesized as electron donors and co-assembled with electron-deficient F4TCNQ to form the corresponding CTCs. The crystalline and photophysical results showed that only herringbone-aligned CTCs (named anion-radical salts, ARS NPs) possess good NIR-II absorption ability and a photothermal effect for short π–π distances (In vitro experiments, FcNEt-F4 NPs, and typical ARS NPs, show outstanding antitumor efficiency for the synergistic effect of NIR-II photothermal therapy and ferroptosis, which provides a new paradigm to develop versatile CTCs for anti-tumor application.
- 20 July 2022
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 13 (32) , 9401-9409
Open AccessCrystal engineering of ferrocene-based charge-transfer complexes for NIR-II photothermal therapy and ferroptosis
Organic charge-transfer complexes (CTCs) can function as versatile second near-infrared (NIR-II) theranostic platforms to tackle complicated solid tumors, while the structure–property relationship is still an unanswered problem. To uncover the effect of molecular stacking modes on photophysical and biochemical properties, herein, five ferrocene derivatives were synthesized as electron donors and co-assembled with electron-deficient F4TCNQ to form the corresponding CTCs. The crystalline and photophysical results showed that only herringbone-aligned CTCs (named anion-radical salts, ARS NPs) possess good NIR-II absorption ability and a photothermal effect for short π–π distances (In vitro experiments, FcNEt-F4 NPs, and typical ARS NPs, show outstanding antitumor efficiency for the synergistic effect of NIR-II photothermal therapy and ferroptosis, which provides a new paradigm to develop versatile CTCs for anti-tumor application.
- 18 July 2022
- Published by Elsevier in Biomaterials
- Vol. 287, 121682
TME-triggered MnSiO3@Met@GOx nanosystem for ATP dual-inhibited starvation/chemodynamic synergistic therapy
- 18 July 2022
- Published by Elsevier in Biomaterials
- Vol. 287, 121682
TME-triggered MnSiO3@Met@GOx nanosystem for ATP dual-inhibited starvation/chemodynamic synergistic therapy
- 2 February 2022
- Published by Wiley in Advanced Healthcare Materials
- Vol. 11 (11) , 2102632
γ‐Fe2O3 Loading Mitoxantrone and Glucose Oxidase for pH‐Responsive Chemo/Chemodynamic/Photothermal Synergistic Cancer Therapy
Traditional cancer therapy is limited by poor prognosis and risk of recurrence. Emerging therapies offer alternatives to these problems. In addition, synergistic therapy can combine the advantages of multiple therapies to eliminate cancer cells while attenuating damage to normal tissues. Herein, a theranostic nanoplatform based on the chemotherapeutic drug mitoxantrone (MTO) and glucose oxidase (GOx) co‐loaded γ‐Fe2O3 nanoparticles (MTO‐GOx@γ‐Fe2O3 NPs) is designed and prepared to realize photoacoustic imaging‐guided chemo/chemodynamic/photothermal (CT/CDT/PTT) synergistic cancer therapy. With a particle size of about 86.2 nm, the synthesized MTO‐GOx@γ‐Fe2O3 NPs can selectively accumulate at tumor sites by enhanced permeability and retention (EPR) effects. After entering cancer cells by endocytosis, MTO‐GOx@γ‐Fe2O3 NPs decompose into Fe3+ ions and release cargo because of their pH‐responsive characteristic. As a Food and Drug Administration (FDA)‐approved chemotherapy drug, MTO shows strong DNA disruption ability and satisfying photothermal conversion ability under laser irradiation for photothermal therapy. Simultaneously, GOx catalyzes the decomposition of glucose and generates hydrogen peroxide (H2O2) to enhance the chemodynamic therapy efficiency. In vitro and in vivo experiments reveal that MTO‐GOx@γ‐Fe2O3 NPs possess a significant synergistic therapeutic effect in cancer treatment.
- 2 February 2022
- Published by Wiley in Advanced Healthcare Materials
- Vol. 11 (11) , 2102632
γ‐Fe2O3 Loading Mitoxantrone and Glucose Oxidase for pH‐Responsive Chemo/Chemodynamic/Photothermal Synergistic Cancer Therapy
Traditional cancer therapy is limited by poor prognosis and risk of recurrence. Emerging therapies offer alternatives to these problems. In addition, synergistic therapy can combine the advantages of multiple therapies to eliminate cancer cells while attenuating damage to normal tissues. Herein, a theranostic nanoplatform based on the chemotherapeutic drug mitoxantrone (MTO) and glucose oxidase (GOx) co‐loaded γ‐Fe2O3 nanoparticles (MTO‐GOx@γ‐Fe2O3 NPs) is designed and prepared to realize photoacoustic imaging‐guided chemo/chemodynamic/photothermal (CT/CDT/PTT) synergistic cancer therapy. With a particle size of about 86.2 nm, the synthesized MTO‐GOx@γ‐Fe2O3 NPs can selectively accumulate at tumor sites by enhanced permeability and retention (EPR) effects. After entering cancer cells by endocytosis, MTO‐GOx@γ‐Fe2O3 NPs decompose into Fe3+ ions and release cargo because of their pH‐responsive characteristic. As a Food and Drug Administration (FDA)‐approved chemotherapy drug, MTO shows strong DNA disruption ability and satisfying photothermal conversion ability under laser irradiation for photothermal therapy. Simultaneously, GOx catalyzes the decomposition of glucose and generates hydrogen peroxide (H2O2) to enhance the chemodynamic therapy efficiency. In vitro and in vivo experiments reveal that MTO‐GOx@γ‐Fe2O3 NPs possess a significant synergistic therapeutic effect in cancer treatment.
- 31 August 2021
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 9 (39) , 8300-8307
Structural effect of NIR-II absorbing charge transfer complexes and its application on cysteine-depletion mediated ferroptosis and phototherapy
Second near-infrared (NIR-II) absorbing organic photothermal agents (PTAs) usually suffer from laborious and time-consuming synthesis; therefore, it is of importance to develop a simple and easy-to-handle method for the preparation of NIR-II PTAs. Charge-transfer complexes (CTCs) can be easily used to construct NIR-II absorbing PTAs, although the relationship between their molecular structure and photophysical properties is yet to be uncovered. Herein, three kinds of electron donors with different substitutions (chloroethyl, ethyl, and methyl) were synthesized and assembled with electron-deficient F4TCNQ to afford corresponding CTC nanoparticles (Cl-F4, Et-F4, and Me-F4 NPs). The large energy gap (>0.61 eV) between HOMO of the donor and LUMO of the acceptor made the CTCs exhibit high charge transfer (>0.93) and dramatic differences in photophysical properties. Additionally, Et-F4 NPs possess the highest NIR-II absorption ability and best photothermal effect because of different packing modes (mass extinction coefficient of 11.0 L g−1 cm−1 and photothermal conversion efficiency of 40.2% at 1060 nm). The mixed stacking mode formed strong charge-transfer absorption bands, indicating that the photophysical properties of CTCs can be tailored by changing the molecular structure and aggregate behaviors. Furthermore, Et-F4 NPs with cyano groups could specifically react with cysteine to block the intracellular biosynthesis of GSH and result in ROS accumulation and ferroptosis. Et-F4 NPs possess outstanding antitumor efficacy for the combined actions of NIR-II triggered photothermal killing effect and ferroptosis in vivo.
- 31 August 2021
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry B
- Vol. 9 (39) , 8300-8307
Structural effect of NIR-II absorbing charge transfer complexes and its application on cysteine-depletion mediated ferroptosis and phototherapy
Second near-infrared (NIR-II) absorbing organic photothermal agents (PTAs) usually suffer from laborious and time-consuming synthesis; therefore, it is of importance to develop a simple and easy-to-handle method for the preparation of NIR-II PTAs. Charge-transfer complexes (CTCs) can be easily used to construct NIR-II absorbing PTAs, although the relationship between their molecular structure and photophysical properties is yet to be uncovered. Herein, three kinds of electron donors with different substitutions (chloroethyl, ethyl, and methyl) were synthesized and assembled with electron-deficient F4TCNQ to afford corresponding CTC nanoparticles (Cl-F4, Et-F4, and Me-F4 NPs). The large energy gap (>0.61 eV) between HOMO of the donor and LUMO of the acceptor made the CTCs exhibit high charge transfer (>0.93) and dramatic differences in photophysical properties. Additionally, Et-F4 NPs possess the highest NIR-II absorption ability and best photothermal effect because of different packing modes (mass extinction coefficient of 11.0 L g−1 cm−1 and photothermal conversion efficiency of 40.2% at 1060 nm). The mixed stacking mode formed strong charge-transfer absorption bands, indicating that the photophysical properties of CTCs can be tailored by changing the molecular structure and aggregate behaviors. Furthermore, Et-F4 NPs with cyano groups could specifically react with cysteine to block the intracellular biosynthesis of GSH and result in ROS accumulation and ferroptosis. Et-F4 NPs possess outstanding antitumor efficacy for the combined actions of NIR-II triggered photothermal killing effect and ferroptosis in vivo.
- 10 June 2021
- Published by Royal Society of Chemistry (RSC) in Materials Chemistry Frontiers
- Vol. 5 (15) , 5798-5805
Nitric oxide-sensitized mitoxantrone chemotherapy integrated with photothermal therapy against multidrug-resistant tumors
Multidrug resistance (MDR) frequently occurs in numerous tumors treated with approved common drugs, which is often associated with the failure of chemotherapy. Therefore, treatment paradigms to reverse MDR in clinics are highly required. Herein, a versatile two-dimensional (2D) nanoplatform (N-GO-MTX-BNN6 NPs) was constructed by anchoring the chemotherapeutic drug mitoxantrone (MTX) and an NO donor (BNN6) on N-doped graphene oxide (N-GO) to fight MCF-7/ADR tumor cells. Nitric oxide (NO) was released by the regulation of UV-vis irradiation, which remarkably inhibited the expression of P-glycoprotein (transmembrane protein) and enhanced the inherent cytotoxicity of MTX by weaking the efflux of hydrophobic drugs. In addition, due to the near-infrared broad absorption of N-GO and MTX, the prepared nanoplatform exhibited an outstanding photothermal performance (η = 53.18%). Both in vitro and in vivo experiments showed that N-GO-MTX-BNN6 NPs can serve as a new approach for the treatment of multidrug-resistant tumors through NO-sensitized chemo/photothermal therapy.
- 10 June 2021
- Published by Royal Society of Chemistry (RSC) in Materials Chemistry Frontiers
- Vol. 5 (15) , 5798-5805
Nitric oxide-sensitized mitoxantrone chemotherapy integrated with photothermal therapy against multidrug-resistant tumors
Multidrug resistance (MDR) frequently occurs in numerous tumors treated with approved common drugs, which is often associated with the failure of chemotherapy. Therefore, treatment paradigms to reverse MDR in clinics are highly required. Herein, a versatile two-dimensional (2D) nanoplatform (N-GO-MTX-BNN6 NPs) was constructed by anchoring the chemotherapeutic drug mitoxantrone (MTX) and an NO donor (BNN6) on N-doped graphene oxide (N-GO) to fight MCF-7/ADR tumor cells. Nitric oxide (NO) was released by the regulation of UV-vis irradiation, which remarkably inhibited the expression of P-glycoprotein (transmembrane protein) and enhanced the inherent cytotoxicity of MTX by weaking the efflux of hydrophobic drugs. In addition, due to the near-infrared broad absorption of N-GO and MTX, the prepared nanoplatform exhibited an outstanding photothermal performance (η = 53.18%). Both in vitro and in vivo experiments showed that N-GO-MTX-BNN6 NPs can serve as a new approach for the treatment of multidrug-resistant tumors through NO-sensitized chemo/photothermal therapy.
- 8 March 2021
- Published by Wiley in Advanced Materials
- Vol. 33 (15) , 2005155
Monotherapy and Combination Therapy Using Anti‐Angiogenic Nanoagents to Fight Cancer
Anti‐angiogenic therapy, targeting vascular endothelial cells (ECs) to prevent tumor growth, has been attracting increasing attention in recent years, beginning with bevacizumab (Avastin) through its Phase II/III clinical trials on solid tumors. However, these trials showed only modest clinical efficiency; moreover, anti‐angiogenic therapy may induce acquired resistance to the drugs employed. Combining advanced drug delivery techniques (e.g., nanotechnology) or other therapeutic strategies (e.g., chemotherapy, radiotherapy, phototherapy, and immunotherapy) with anti‐angiogenic therapy results in significantly synergistic effects and has opened a new horizon in fighting cancer. Herein, clinical difficulties in using traditional anti‐angiogenic therapy are discussed. Then, several promising applications of anti‐angiogenic nanoagents in monotherapies and combination therapies are highlighted. Finally, the challenges and perspectives of anti‐angiogenic cancer therapy are summarized. A useful introduction to anti‐angiogenic strategies, which may significantly improve therapeutic outcomes, is thus provided.
- 8 March 2021
- Published by Wiley in Advanced Materials
- Vol. 33 (15) , 2005155
Monotherapy and Combination Therapy Using Anti‐Angiogenic Nanoagents to Fight Cancer
Anti‐angiogenic therapy, targeting vascular endothelial cells (ECs) to prevent tumor growth, has been attracting increasing attention in recent years, beginning with bevacizumab (Avastin) through its Phase II/III clinical trials on solid tumors. However, these trials showed only modest clinical efficiency; moreover, anti‐angiogenic therapy may induce acquired resistance to the drugs employed. Combining advanced drug delivery techniques (e.g., nanotechnology) or other therapeutic strategies (e.g., chemotherapy, radiotherapy, phototherapy, and immunotherapy) with anti‐angiogenic therapy results in significantly synergistic effects and has opened a new horizon in fighting cancer. Herein, clinical difficulties in using traditional anti‐angiogenic therapy are discussed. Then, several promising applications of anti‐angiogenic nanoagents in monotherapies and combination therapies are highlighted. Finally, the challenges and perspectives of anti‐angiogenic cancer therapy are summarized. A useful introduction to anti‐angiogenic strategies, which may significantly improve therapeutic outcomes, is thus provided.
- 3 November 2020
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 56 (94) , 14865-14868
pH/glutathione-responsive release of SO2 induced superoxide radical accumulation for gas therapy of cancer
A pH/glutathione (GSH)-responsive SO2 generation nanoplatform (BODS NPs) is established to achieve lysosomal escape and GSH depletion in tumors to sensitize the SO2-mediated oxidative stress.
- 3 November 2020
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 56 (94) , 14865-14868
pH/glutathione-responsive release of SO2 induced superoxide radical accumulation for gas therapy of cancer
A pH/glutathione (GSH)-responsive SO2 generation nanoplatform (BODS NPs) is established to achieve lysosomal escape and GSH depletion in tumors to sensitize the SO2-mediated oxidative stress.